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ABSTRACT The free energy potential (affinity) for aggregation of human red blood cells and lipid vesicles in Dextran
solutions and blood plasma has been quantitated by measuring to what extent a vesicle is encapsulated by the red cell
surface. The free energy reduction per unit area of contact formation (affinity) was computed from the observation of
the fractional extent of encapsulation at equilibrium with the use of a relation based on the elastic compliance of the red
cell membrane as it is deformed to adhere to the vesicle surface. Micromanipulation methods were used to select and
transfer single lipid vesicles (2-3 x 10-4 cm diameter) from a chamber that contained the vesicle suspension to a
separate chamber on the microscope stage that contained red cells in an EDTA buffer with Dextran or whole plasma.
The vesicle and a red cell were maneuvered into close proximity and contact allowed to take place without forcing the
cells together. To evaluate the effects of surface charge density and steric interactions on aggregation, vesicles were
made from mixtures of egg phosphatidylcholine (PC) and bovine phosphatidylserine (PS) over a range of mole ratios
(PC/PS)from (1:0) to (1:1); the vesicles were formed by rehydration in buffer. The Dextran solutions were made with a
sharp-cut fraction of 36,500 MW in a concentration range of 0-10% by weight in grams (wt/wt). It was found that the
Dextran 36,500 MW fraction produced aggregation behavior for red cells and vesicles similar to red cell-red cell
aggregation in Dextran 70,000-150,000 MW fractions, when the vesicle surface charge density was comparable with
that of normal red cells (i.e., PC/PS ratio of -3:1). This result indicated that Dextran molecules penetrate between the
carbohydrate groups on the red cell surface and that either steric interactions between cell surface carbohydrates are
important or many of the charge groups on red cells are superficial. Electrostatic repulsion effects were apparent, as no
aggregation in Dextran 36,500 MW occurred for PC/PS ratios <2.6:1; the level of affinity increased with the PC
content at a specific Dextran concentration. Affinities were measured in the range of 0-2 x 10-2 ergs/cm2. When
adherent red cell-vesicle pairs were transferred into a Dextran-free buffer, the pair did not spontaneously separate.
They maintained adhesive contact until forcibly parted, after which they would not readhere. This demonstrates that
Dextran forms a "cross-bridge" between the membrane surfaces. Red cell-vesicle aggregation was also tested in whole
plasma, which normally yields affinity values in the range of 2-4 x 10-3 ergs/cm2 for red cell-red cell aggregation.
However, no red cell-vesicle aggregation occurred in plasma, even for pure PC vesicles. This result indicates that either
the aggregating plasma proteins (primarily fibrinogen) do not bind sufficiently to the lecithin surface, or they are
shielded from binding to the surface by the presence of other nonaggregating components (perhaps albumin).
INTRODUCTION low concentrations of <1% by weight in grams (wt/wt), (c)
aggregation of normal red cells does not occur for Dextran
Plasma proteins and Dextran, a glucose polymer, promote concentrations above 5-10% by weight in grams, and (d)
aggregation of red blood cells in solution. The aggregates aggregation depends on cell surface charge. Thus, there is
exhibit close, uniformly spread cell-cell contact over large a window of Dextran concentrations within which normal
areas of the cell surfaces. Important features of the aggre- red cells are aggregated; outside this window, aggregation
gation have been well described by Brooks (1973 b), and does not occur even though the adsorption of Dextran is not
Chien and associates (Jan and Chien, 1973): (a) normal saturated (Brooks, 1973 a; Brooks et al., 1980; and Chien,
red cells are not aggregated by Dextrans with molecular 1980). These features have been verified in controlled
weights less than -50,000, (b) aggregation commences at aggregation tests of single red blood cells; in addition, the
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level of chemical affinity between red cell membranes has
been determined in these tests as a function of Dextran
concentration and molecular weight (Buxbaum et al.,
1982). The affinity between membrane surfaces is defined
by the reduction in free energy per unit area that is
associated with the initial formation of adhesive contact.
As such, the potential for cells to aggregate is represented
by surface affinity. Values of affinity for normal red cells
range from low values characteristic of aggregation in
plasma (10' ergs/cm2) to values above 10-2 ergs/cm2 in
solutions of 150,000 MW Dextran (Buxbaum et al., 1982).
The peak affinityfor aggregation of normal cells goes up
with Dextran molecular weight. When cells have been
treated with neuraminidase to partially remove cell surface
charge (Haydon and Seaman, 1967), the levels of affinity
are much higher for a given molecular weight and concen-
tration of Dextran. Also, molecular weights as low as
28,000 give measurable levels of affinity between neuram-
inidase-treated cells. This demonstrates that electrostatic
repulsion is a prominent mechanism in red cell aggrega-
tion. In addition, it has been proposed (Brooks, 1973 b)
that the adsorption of Dextran may act to expand the
electric double layer and thus be responsible for quenching
the aggregation process at high Dextran concentrations.
This thesis was consistent with the observation that
removal of large amounts of cell surface charge by neu-
raminidase treatment appeared to abolish the quenching
affect and with the observed effect of ionic strength on the
quenching concentration.
The cell-surface charge is distributed in a thick layer of
carbohydrate groups on the red cell membrane (Steck and
Dawson, 1974; Steck, 1974); thus,it is difficult to separate
electrostatic repulsion from steric interactions that occur
between red cell surfaces. Enzymatic removal of these
groups clearly affects both interactions. To evaluate the
effects of cell-surface charge distribution and density on
cell aggregation, we have performed controlled aggrega-
tion tests of single red blood cells with large lipid vesicles
made from mixtures of egg phosphatidylcholine (PC) and
bovine phosphatidylserine (PS). From these tests, we have
derived the affinity (defined by the free energy reduction
per unit area of contact) between the red cell and vesicle
membrane as a function of the vesicle surface charge
density and Dextran concentration. Similarly, we have
examined the potential for aggregation of red cells and
lipid vesicles in native plasma.
EXPERIMENTAL PROCEDURES
Experiments were performed with red blood cells (RBC) from a single
healthy donor (type 0, Rh') obtained by finger prick. The cells were
suspended at very low hematocrit in either filtered plasma or phosphate
buffered saline (PBS)-Dextran solution that contained human serum
albumin (0.5% by weight in grams). The presence of albumin had no
affect on the aggregation; however, it did preserve the discoidal shape of
the red cells and eliminated adhesion to the glass micropipettes.
Plasma was obtained as the supernate from blood-type compatible
samples centrifuged at 8,000 g and room temperature for 2 min to remove
cells. The buffy coat and red cells were removed, then the plasma was
filtered. Concentrated stock solutions of Dextran (36,500 MW) were
made in distilled water with 0.2% by weight in grams sodium azide to
retard bacterial growth. Concentrations of stock solutions were accurately
measured by polarimetry. Subsequent dilutions of the Dextran stock
solution into concentrated PBS were made before experimentation to
obtain the desired concentration and ionic strength. The PBS contained
25-30 mM phosphate to maintain PH at 7.4, 0.1 mM EDTA, with the
final osmotic strength of 250 mOsM. The hypoosmotic buffer was used to
slightly swell the red cells and vesicles for better observation of the vesicle
encapsulation. The Dextran was a sharp-cut fraction with a weight-
averaged molecular weight of 36,500 and a ratio of weight average to
number average molecular weights of 1.34 (kindly supplied by Dr. Kirsti
Granath, Pharmacia designation FDR 7314, Pharmacia Fine Chemicals,
Div. Pharmacia Inc., Piscataway, NJ).
Vesicles were prepared from stock solutions of PC/PS mixtures (PC,
Sigma Chemical Co., St. Louis, MO; PS, Avanti Polar Lipids, Inc.,
Birmingham, AL; both components 99% pure) in chloroform methanol
(9:1 solution). The stock solutions were stored in a freezer at -10°C.
Aliquots of the stock solutions were dried under argon and placed in vacuo
for 4-5 h. The samples were then suspended in 270 mOsM sucrose buffer
containing 0.1 mM EDTA and allowed to sit for I h at room temperature.
Finally, the vesicle suspension in sucrose was dialyzed overnight against
270 mOsM PBS to provide the test suspension.
To prevent aggregation of small vesicles and lipid debris to the red
cells, the vesicle and red cell suspensions were placed in separate
chambers on the microscope stage. The experimental procedure was to
select a vesicle (2-3 gm diam) with one suction micropipette, insert the
vesicle inside a much larger pipette (-15 ,um i.d.), then translate the
microscope stage to transfer the micropipette assembly into the second
chamber. The vesicle was then removed from the large, transfer pipette
and held with sufficient suction pressure to leave a rigid spherical portion
outside the micropipette. Next, a red cell was aspirated with a third
pipette at such a low suction pressure that little deformation of the red cell
occurred. Fig. I A shows a vesicle and red cell held by micropipettes
before the aggregation test. Finally, the red cell was maneuvered into
position proximal to the vesicle surface (but not forced to spread over the
vesicle), contact was allowed to take place, and the red cell suction pipette
was removed. The equilibrium contact was observed as shown in Fig. 1 B.
All experiments were performed at room temperature. When no sponta-
neous aggregation occurred, the red cell was released from the pipette in a
position slightly above the vesicle and allowed to settle on the vesicle
surface by gravity. If there was no potential for aggregation, then the red
cell simply fell off the vesicle and floated away. The aggregation was
quantitated by measurement of the fractional extent of encapsulation of
the spherical vesicle surface at equilibrium. This was determined from-
measurements of the cap height, Z¢, at the contact zone and the vesicle
diameter, 2 R,, as illustrated in Fig. 1 C. The fractional extent of
encapsulation is defined by x - Z,/2R,. As will be discussed in the next
section, it has been shown that the fractional extent of encapsulation, x, of
a spherical surface by a red blood cell is a progressive function of the
affinity between the red cell and sphere surfaces (Evans and Buxbaum,
1981). This relationship is derived from the free energy for elastic
deformation of the red cell membrane as it conforms to the sphere. Hence,
the observation of encapsulation provides a direct method to quantitate
the potential for red cell-vesicle aggregation. The practical limit for
measurement of the encapsulation is x - 0.7. Values above 0.7 are often
accompanied by folding of the red cell membrane and are intrinsically
difficult to measure because the cell obscures the view of the vesicle.
Because vesicles are transparent, it was necessary to use interference
contrast optics to observe the vesicle geometry.
RESULTS AND ANALYSIS
Because the RBC has -3 x 1013 charges/cm2 (Seaman et
al., 1977; Levine et al., 1983), we investigated a range of
PC/PS ratios from 1:0 to 1:1 which approximately repre-
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cFIGURE 1 (a) Videomicrograph of a human red blood cell and lecithin vesicle held by micropipettes before aggregation in PBS-Dextran
36,500 MW solution. The major diameter of the red cell is -8 x 10 'cm; the inner diameters of the pipettes are -I x 1o4cm. The image is
enhanced by differential interference contrast optics. (b) Video micrograph of the equilibrium configuration of the red cell adhered to the
vesicle after the cell was maneuvered into proximity of the vesicle and contact was allowed to take place. The red cell was observed to spread
spontaneously over the vesicle surface without forcing the two capsules together. The extent of encapsulation is directly related to the affinity
between the red cell and vesicle surfaces. (c) Minimum-energy contour, computed for a red cell encapsulation of a spherical substrate, that
illustrates the parameters measured in each experiment, i.e., the cap height, Zc, and the vesicle diameter, 2R,. The fractional extent of
encapsulation is given by x = Z,/2R,.
sents a range of charge densities from 0-7 x 10'3/cm2 (i.e.,
twice the RBC level). The estimates of charge densities for
mixed lipids are calculated with the assumptions that the
area per lipid head group is the same for either component
and equal to 70 A2 per molecule. The assumptions are
based on evidence from x-ray diffraction that the area per
lipid head group in salt solutions is not greatly affected by
the charge on the head group (Luzzati, 1968; Cowley et al.,
1978). In our experiments, it was found that Dextran
36,500 MW produced RBC-vesicle aggregation behavior
similar to RBC-RBC aggregation in Dextran 70,000 and
150,000 MW (Baxbaum et al., 1982) when the vesicle
charge densities were comparable to RBC values. Thus,
the aggregation tests were carried out with the sharp-cut
Dextran 36,500 MW fraction. Data on the extent of
encapsulation, x, as a function of Dextran concentration
are cumulated in Fig. 2 for PC/PS ratios of 1:0, 4:1, 3:1,
and 2.7:1. No RBC-vesicle aggregation was observed for
PC/PS ratios <2.6:1 in Dextran 36,500 MW. For PC/PS
compositions in the range of 4:1 to 2.7:1, the RBC-vesicle
aggregation occurred in the same window of concentra-
tions as RBC-RBC aggregation in Dextran 70,000 and
150,000 MW solutions. The data points are averages for
10-15 RBC-vesicle aggregation tests; the average values
for the extent of encapsulation are shown bracketed by
typical standard deviations of the measurements. The
hand-drawn curves simply indicate the data characteristics
and are not numerical correlations. As with RBC-RBC
aggregation in Dextran, there existed an upper concentra-
tion of Dextran above which the aggregation was
quenched. The concentration, where quenching com-
menced, was observed to depend on the vesicle surface
charge density. Similarly, the onset of aggregation was
observed to depend on Dextran concentration and vesicle
surface density as with RBC-RBC aggregation in Dextran
before and after neuraminidase treatment (Buxbaum et
al., 1982). Fig. 3 is a plot of the threshold concentrations
that bracket the RBC-vesicle aggregation vs. the mole
fraction of PS. The solid line represents the behavior for
the onset of aggregation and the dotted line characterizes
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FIGURE 2 Observations of the fractional extent of encapsulation of a
lecithin vesicle surface by a red blood cell vs. the concentration (wt/wt) of
Dextran 36,500 MW polymer in solution for different PC/PS ratios. The
data points are averages of 10-15 RBC-vesicle tests; the error bars are
shown for the largest standard deviation in the observations. The curves
were hand drawn to indicate the data characteristics. The breaks along
the abscissa are the upper and lower concentration limits where aggrega-
tion was observed to either commence or cease for a given vesicle
composition. Aggregation was observed for vesicle compositions in the
range from pure PC and no PS (1:0) to 72% PC and 28% PS (2.6:1).
the upper concentration where the aggregation process was
quenched. The curves converge at the PS fraction equiva-
lent to a PC/PS ratio of 2.6:1, which was the maximum
charge content where aggregation (very weak) could be
observed. For pure vesicles (1:0), the aggregation appeared
to increase without bound although no useful measure-
ments could be made above 1% by weight in grams because
the fractional encapsulation of the vesicle was >0.7. Even
for Dextran concentrations as high as 25% by weight in
grams, the encapsulation was greater than the observation
limit. Higher concentrations were extremely difficult to
use because of the high viscosity of the solutions. In support
of the RBC-PC vesicle observations, our recent measure-
ments of affinity for pure PC vesicle-vesicle aggregation
show a linear increase with concentration over this range of
Dextran concentrations (Evans and Metcalfe, submitted
for publication).
We demonstrated that the Dextran molecules definitely
form "cross-bridges" between the two membrane surfaces
by the following test: after the red cell had formed adhesive
contact with the vesicle, we transferred the red cell-vesicle
pair to an adjacent chamber that contained only buffer
with no Dextran in solution. The red cell remained adher-
FIGURE 3 Plot of the threshold concentrations for the onset ( ) and
quenching (.-**) of the RBC-vesicle aggregation vs. the mole fraction of
PS, i.e., PS/(PC + PS). The region under the curves represents the
conditions where aggregation occurred in Dextran 36,500 MW solutions.
ent to the vesicle for as long as we chose (- 1 h). When the
red cell and vesicle were forced to separated (by micro-
manipulation), no reaggregation was possible.
Because RBC-RBC aggregation in plasma is compara-
ble with aggregation in Dextran 70,000 MW and also with
the RBC-vesicle aggregation in Dextran 36,500 MW, we
set out to determine the PC/PS ratio that would give
comparable RBC-vesicle aggregation in plasma. A very
surprising result was obtained: no RBC-vesicle aggrega-
tion occurred in plasma even for pure PC vesicles without
charge. This result indicates that either the aggregating
plasma proteins (primarily fibrinogen) do not bind suffi-
ciently to the lecithin surface or these aggregating plasma
proteins are shielded from binding to the surface by the
presence of other nonaggregating constituents (e.g., albu-
min). As stated in the last section, the fractional extent of
encapsulation of the vesicle by the red cell surface at
equilibrium provides a direct measure of the surface-
to-surface affinity. This free energy reduction per unit area
of contact formation is derived from the elastic compliance
of the red cell membrane as it is deformed to cover the
sphere. The equilibrium conformation is established when
small (virtual) increases in elastic deformation energy of
the red cell are just balanced by small (virtual) decreases in
the free energy due to contact, i.e.,
a WD
aAc'
(1)
where y is the affinity (in ergs per square centimeter); WD
is the elastic work of deformation(in ergs); A, is the contact
area between the RBC and vesicle (in square centimeters).
Because the red cell interior is liquid, the reversible work of
cell deformation depends only on the membrane elastic
properties and the membrane deformation. It has been
shown that the compliance relation (Eq. 1) for red cell
encapsulation of a spherical surface is well approximated
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by
,y - ,g[x1(1 - x) -x * In (I-x)] + B[21R's
+ (2t/B * R2)'1/2* x . (1 + 3x/8 + x2/4)], (2)
where ,u is the elastic shear (extensional) modulus and B is
the bending elastic modulus of the RBC membrane (Evans
and Buxbaum, 1981). This relation is not affected by the
size of the sphere (other than through the bending term
shown in Eq. 2) provided that the red cell has sufficient
surface area in relation to its volume to allow for encapsu-
lation of the sphere without increase in surface area. The
practical size limit for spherical particles is -3 ,um when
the RBC are in isotonic media. If the sphere is too large to
be encapsulated, the membrane tension builds up rapidly
in proportion to the affinity at essentially a fixed extent of
encapsulation determined by the surface area and volume
of the RBC (Evans and Parsegian, 1983).
The elastic properties of the RBC membrane have been
measured and exhibit little variation between normal,
healthy individuals. The membrane shear modulus is in the
range of 6-7 x 10-3 erg/cm (Waugh and Evans, 1979).
The membrane bending or curvature elastic modulus is not
known as precisely because of its small value; but within a
factor of 2, it is 1 x 10- 12 erg (Evans, 1980; Evans, 1983).
Hence, for vesicles on the order of 1 ,tm in radius, the
bending elastic contribution to the compliance relation
(Eq. 2) is small. Also, our measurements and the extensive
work of Nash and Meiselman (1983) have shown that the
elastic behavior of the RBC membrane is not affected by
Dextran adsorption. Thus, with these elastic properties, the
observations of the extent of encapsulation shown in Fig. 2,
and the compliance relation from Eq. 2, we have derived
the levels of membrane-membrane affinity for aggregation
of RBC and vesicles in the Dextran solutions. The results
are plotted in Fig. 4 for the data characteristics sketched in
Fig. 2. Fig. 4 represents the free energy potential for
aggregation ofRBC and mixed PC/PS vesicles in solutions
of Dextran 36,500 MW.
DISCUSSION
The affinity levels for RBC-PC/PS vesicle aggregation in
Dextran 36,500 MW solutions are comparable with the
values determined previously for RBC-RBC aggregation
in Dextran 70,000 and 150,000 MW solutions, i.e., on the
order of 1-2 x 10-2 erg/cm2 or less. Also, the window of
concentrations for the aggregation is similar in both cases
when the vesicle surface charge density is comparable with
that of the normal RBC. It is obvious, however, that the
size of the Dextran 36,500 MW is much smaller than
either the 70,000 or 150,000 MW molecules (the size in
solution varies approximately as the square root of the
molecular weight. The peak level of affinity at a given
Dextran concentration increases with the PC content.
Also, both the onset and quenching of aggregation
depended on the vesicle surface charge density, but no
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FIGURE 4 Free energy potential (affinity) for aggregation of RBC and
mixed (PC/PS) vesicles in Dextran 36,500 MW solutions. The curves are
based on the data characteristics shown in Fig. 2 and the elastic
compliance relation (Eq. 2) for deformation of the red cell membrane as it
encapsulates the spherical vesicle surface. The scale for affinity is
established by measurements of the elastic shear and bending moduli of
the red cell membrane.
quenching affect was observed with neutral lipid vesicles.
As was noted previously, RBC-RBC and RBC-lipid vesicle
aggregation in Dextran solutions and in plasma are dif-
ferent in that there was no RBC-vesicle aggregation (even
for uncharged lipid) in plasma, which indicates that either
the aggregating proteins in plasma do not adsorb to the
lecithin surface or are shielded from the surface by another
adsorbed component.
One obvious explanation (there may be others as well)
for the result that small Dextran molecules can produce
red cell-charged vesicle adhesion as effectively as larger
Dextrans do in red cell-red cell adhesion is the following: if
Dextran molecules need to penetrate between the surface
carbohydrates on the red cell to produce cross-bridges,
then larger molecules would be required for red cell-red
cell adhesion than for red cell-vesicle adhesion where the
vesicle surface is much "smoother. " In addition, penetra-
tion would increase the likelihood of steric interactions
between carbohydrates on opposite red cell surfaces and
would cause the interaction between superficial charge
groups on these cell surfaces to be stronger. As it appears
that Dextran molecules have to penetrate the surface
carbohydrate layer to form cross-bridges, it is possible that
the exposed regions (between carbohydrates) become satu-
rated with Dextran and that further adsorption interferes
with (quenches) the aggregation process. This speculation
is consistent with our observation tht vesicle-vesicle aggre-
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gation in Dextran is not quenched at high concentrations
(Evans and Metcalfe, submitted for publication); quench-
ing is definitely associated with the presence of surface
carbohydrate groups.
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